Acetylation of p53 Inhibits Its Ubiquitination by Mdm2
Open accessThe DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
In response to DNA damage, the activity of the p53 tumor suppressor is modulated by protein stabilization and post-translational modifications including acetylation. Interestingly, both acetylation and ubiquitination can modify the same lysine residues at the C terminus of p53, implicating a role of acetylation in the regulation of p53 stability. However, the direct effect of acetylation on Mdm2-mediated ubiquitination of p53 is still lacking because of technical difficulties. Here, we have developed a method to obtain pure acetylated p53 proteins from cells, and by using an in vitro purified system, we provide the direct evidence that acetylation of the C-terminal domain is sufficient to abrogate its ubiquitination by Mdm2. Importantly, even in the absence of DNA damage, acetylation of the p53 protein is capable of reducing the ubiquitination levels and extending its half-life in vivo. Moreover, we also show that acetylation of p53 can affect its ubiquitination through other mechanisms in addition to the site competition. This study has significant implications regarding a general mechanism by which protein acetylation modulates ubiquitination-dependent proteasome proteolysis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“upon DNA damage, p53 becomes acetylated at multiple residues within its C-terminal domain to stabilize the protein via directly blocking ubiquitination at acetylated sites as well as hindering the interaction between p53 and MDM2 to discourage ubiquitination at unacetylated sites [47,48].”
From Acetylation: a new target for protein degradation in cancer (2025) · cites this paper as [48]
Citations
Cites
Vogelstein, B., Lane, D., & Levine, A. J. (2000) · Nature · doi:10.1038/35042675 · Cited by 6,607
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506
Regulation of p53 stability by Mdm2
Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312
Mechanisms Underlying Ubiquitination
Pickart, C. M. (2001) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.70.1.503 · Cited by 3,184
Activation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain
Gu, W., & Roeder, R. G. (1997) · Cell · doi:10.1016/s0092-8674(00)80521-8 · Cited by 2,559
Self-citationDNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2
Shieh, S.-Y., Ikeda, M., Taya, Y., & Prives, C. (1997) · Cell · doi:10.1016/s0092-8674(00)80416-x · Cited by 2,100
Negative Control of p53 by Sir2α Promotes Cell Survival under Stress
Luo, J., Nikolaev, A. Y., Imai, S.-I., Chen, D., Su, F., Shiloh, A., Guarente, L., & Gu, W. (2001) · Cell · doi:10.1016/s0092-8674(01)00524-4 · Cited by 2,081
Self-citationThe HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53
Scheffner, M., Huibregtse, J. M., Vierstra, R. D., & Howley, P. M. (1993) · Cell · doi:10.1016/0092-8674(93)90384-3 · Cited by 2,054
Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53
Honda, R., Tanaka, H., & Yasuda, H. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01480-4 · Cited by 1,951
Acetylation of Histones and Transcription-Related Factors
Sterner, D. E., & Berger, S. L. (2000) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.64.2.435-459.2000 · Cited by 1,780
Research works printed but not linked: 1
- Appella, 2000, Pathol. Biol. (Paris), 48, 227
Cited by
Items 401–500 of 520
Cellular and molecular biology of posttranslational modifications in cardiovascular disease
Zhu, L., Liu, Y., Huang, Y., Zhou, Z., Liu, J., Yu, L.-M., & Wang, H. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117374 · Cited by 8
Tüzün, B., Ağbektaş, T., Naghiyev, F. N., Taş, A., Zontul, C., Özüm, Ü., Khalilov, A. N., Siliğ, Y., Çakmak, N. K., & Mamedov, I. G. (2025) · Monatshefte für Chemie - Chemical Monthly · doi:10.1007/s00706-025-03315-7 · Cited by 7
Węsierska‐Gądek, J., Gueorguieva, M., Herbacek, I., & Ranftler, C. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1397.006 · Cited by 7
Choi, S., Koh, D., Cho, S.-Y., Kim, M.-K., Kim, K., & Hur, M. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.008100 · Cited by 7
TRANSCRIPTION FACTORS AND HUMAN DISEASE
Latchman, D. S. (2008) · Elsevier eBooks · doi:10.1016/b978-012373983-4.50017-1 · Cited by 7
Purification of acetyl-p53 using p300 co-infection and the baculovirus expression system
Piluso, L. G., Wei, G., Li, A. G., & Liu, X. (2005) · Protein Expression and Purification · doi:10.1016/j.pep.2004.12.015 · Cited by 8
Hasegawa, M., Ishiguro, K., Ando, T., & Goto, H. (2012) · PubMed · doi:10.18999/nagjms.74.1-2.123 · Cited by 6
Yu, X., Ponce, R. A., & Faustman, E. M. (2011) · Springer eBooks · doi:10.1007/978-94-007-0428-2_14 · Cited by 6
The advances in acetylation modification in senescence and aging-related diseases
Xu, M., Wang, W., Lu, S., Xiong, M., Zhao, T., Yu, Y., Song, C., Yang, J., Zhang, N., Cao, L., et al. (2025) · Frontiers in Physiology · doi:10.3389/fphys.2025.1553646 · Cited by 6
Disordered but rhythmic—the role of intrinsic protein disorder in eukaryotic circadian timing
Usher, E. T., & Pelham, J. F. (2025) · FEBS Letters · doi:10.1002/1873-3468.70238 · Cited by 5
Pandora’s Box of AML: How TP53 Mutations Defy Therapy and Hint at New Hope
Olesinski, E. A., & Bhatt, S. (2025) · Biomedicines · doi:10.3390/biomedicines13123007 · Cited by 6
Acidic domain is indispensable for MDM2 to negatively regulate the acetylation of p53
Wang, Q., Yang, Y., Wang, L., Zhang, P., & Yu, L. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.07.038 · Cited by 6
Histone deacetylase inhibitors and Hodgkin's lymphoma
Kirschbaum, M. H. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70327-8 · Cited by 5
p53 regulation by ubiquitin and ubiquitin-like modifications
Wang, Y., Zhang, C., Wang, J., & Liu, J. (2022) · Genome Instability & Disease · doi:10.1007/s42764-022-00067-0 · Cited by 5
Refining sugar's involvement in cholesterol synthesis
Fenton, N., Nguyen, T. B., Sharpe, L. J., & Brown, A. J. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2022.159266 · Cited by 5
Coppedè, F., Bosco, P., Fuso, A., & Troen, A. M. (2012) · Current Gerontology and Geriatrics Research · doi:10.1155/2012/926082 · Cited by 9
Yang, Y., Li, S., Li, Y., Lv, L., Ye, D., Kang, J., Yu, T., Wang, Y., & Wu, H. (2023) · Cancer Gene Therapy · doi:10.1038/s41417-023-00665-4 · Cited by 4
MDM2–GPX4–ferroptosis regulatory axis exerts neurotoxic effects in intracerebral hemorrhage
Yu, Y.-H., Liu, T., Cai, Y., Song, Y., Zhou, H., Cao, F., & Jiang, R. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-25-00030 · Cited by 6
Critical Role of Lysine 123 in the Ubiquitin-Mediated Degradation of MDA-7/IL-24
Tian, H., Li, L., Zhang, B., Di, J., Chen, F., Li, H., Liu, J., Pei, D., & Zheng, J.-N. (2012) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2012.0055 · Cited by 4
Ma, R., Zhang, M., Xi, J., Li, J., Ma, Y., Han, B., Che, T., Ma, Z., Tian, J., & Bai, Z. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.978464 · Cited by 4
Ranftler, C., Gueorguieva, M., & Węsierska‐Gądek, J. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1378.026 · Cited by 4
The Role of p53 Protein in the Regulation of Neuronal Differentiation
Glazova, M. V. (2016) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-016-0342-6 · Cited by 4
Manav, N., Sharma, P., Mochan, S., & Malhotra, L. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.143883 · Cited by 3
Xiang, J., Wang, S., Zhang, G., Jiao, L., Ling-yun, F., Xu, Y., Wang, Y., Li, X., Tao, J., Yang, X., et al. (2026) · Phytotherapy Research · doi:10.1002/ptr.70209 · Cited by 3
Maeda, A., Nakamura, S., Isono, M., Osaki, M., Ito, H., & Sato, K. (2006) · Pathology International · doi:10.1111/j.1440-1827.2006.01934.x · Cited by 3
Transcription Factors and Human Disease
Latchman, D. S. (2004) · Elsevier eBooks · doi:10.1016/b978-012437178-1/50015-1 · Cited by 4
Cellular lifespan and senescence: a complex balance between multiple cellular pathways
Dolivo, D., Hernandez, S. J., & Dominko, T. (2015) · Inside the Cell · doi:10.1002/icl3.1036 · Cited by 3
Characterization of the E3 Ubiquitin Ligase Pirh2
Tai, E. (2010) · TSpace (University of Toronto) · Cited by 5
LINE1 insertion into the NACC2 locus disrupts the HDM2 axis and activates lung oncogenic signaling
Bojang, P., Wang, Y., & Ramos, K. S. (2025) · npj Precision Oncology · doi:10.1038/s41698-025-01050-0 · Cited by 2
Singh, N. K., Ahmad, F., & Husain, A. (2026) · Pathology - Research and Practice · doi:10.1016/j.prp.2026.156506 · Cited by 3
Fu, Z., Shi, R., Jiang, L., Zhang, W., Liu, Y., Chen, W., Zhu, F., Chen, R., Jin, G., Chen, Y., et al. (2026) · Cell investigation. · doi:10.1016/j.clnves.2026.100078 · Cited by 3
Dong, Y., & Zou, S. (2009) · Springer eBooks · doi:10.1007/978-1-4419-0639-7_5 · Cited by 2
Tumorvirologie, A. F., & Klotzsche, O. (2005) · Cited by 2
The Structural Biology of Ubiquitin–Protein Ligases
Zheng, N., & Pavletich, N. P. (2007) · Wiley eBooks · doi:10.1002/9783527619320.ch7 · Cited by 2
Tehlan, A., Nagar, P., Prajapati, R., Bhowmick, K., Kumar, A., Kaur, I., Subbarao, N., & Dhar, S. K. (2025) · FEBS Journal · doi:10.1111/febs.70164 · Cited by 1
Wu, Y., Luo, M., Hu, L., Wu, L., Zhu, X., Zhu, H., Shen, S., Zhao, Y., Li, X., Tao, J., et al. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.121120 · Cited by 1
Boddu, M., Dev, A., & Karmakar, S. (2026) · Small · doi:10.1002/smll.202512024 · Cited by 1
Wang, T., Zang, Y., Wei, Q., Zeng, R., Lu, J., & Wang, Q. (2026) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2026.151362 · Cited by 1
Damage and Replication Stress Responses
Wang, H., Shen, P., & Zhu, W. (2011) · InTech eBooks · doi:10.5772/21986 · Cited by 1
Role of Central Insulin-Like Growth Factor-1 Receptor Signalling in Ageing and Endocrine Regulation
Moll, L., Zemva, J., & Schubert, M. (2011) · InTech eBooks · doi:10.5772/22924 · Cited by 2
The Function of YY1 and Its Oncogenic Role in Prostate Cancer
Bui, D., & Sui, G. (2013) · InTech eBooks · doi:10.5772/53091 · Cited by 3
Zhu, W. (2010) · ScholarlyCommons (University of Pennsylvania) · Cited by 1
Rapid Detection of p53 Acetylation Status in Response to Cellular Stress Signaling
Farkaš, M., & McMahon, S. B. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9434-2_15 · Cited by 1
Lai, S., Higuchi, T., Tsuda, M., Sugiyama, Y., Morisawa, K., Taniguchi, T., & Sakamoto, S. (2022) · Scientific Reports · doi:10.1038/s41598-022-12600-y · Cited by 1
Altered regulation of PTEN by mutagenesis and p85 binding
Pastor, M. (2008) · University Library - University of Saskatchewan (University of Saskatchewan) · Cited by 1
Proteasomes and Other Nanocompartmentalized Proteases of Archaea
Maupin-furlow, J. A., Gil, M. A., Humbard, M. A., Kirkland, P. A., Li, W., Reuter, C. J., & Wright, A. J. (2006) · Microbiology monographs · doi:10.1007/7171_019 · Cited by 1
Complex regulation of Forkhead Box O transcription factors
van den Berg, M. C. W. (2013) · Utrecht University Repository (Utrecht University) · Cited by 1
The p53 Transcription Factor as Therapeutic Target in Cancer
Asker, C., Bykov, V. J. N., Méndez‐Vidal, C., Selivanova, G., Wilhelm, M., & Wiman, K. G. (2004) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-18932-6_7 · Cited by 1
Tumor suppressor p53 and transcriptional changes in cellular stress responses to UV radiation
Latonen, L. (2003) · Helda - University of Helsinki Institutional Repository
THE ROLE OF P53 IN OXIDATIVE STRESS AND POLYGLUTAMINE NEUROTOXICITY
Dunn, J. C. (2003) · UKnowledge (University of Kentucky)
A novel phosphatase modulating the DNA damage response and the tumor suppressor p53
Marinoglou, K. (2011) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-3254
Biochemical analysis of the basic helix-loop-helix transcription factor Olig2
Meijer, D. H. (2014) · Utrecht University Repository (Utrecht University)
Regulation of bax activation and apoptosis by src and acetylated mutant p53
Woods, N. T. (2008) · Digital Commons - University of South Florida (University of South Florida)
Regulation of FOXO stability and activity by MDM2 E3 ligase
Fu, W. (2007) · Digital Commons - University of South Florida (University of South Florida)
Regulation of Estrogen Receptor alpha Ubiquitination and Proteasome-mediated Receptor Degradation
Berry, N. B. (2008) · IUScholarWorks (Indiana University) · Cited by 1
Studies of mutant p53-targeting small molecules
Zache, N. (2007) · Figshare
Riss, A. (2012) · theses.fr (ABES) · doi:10.70675/5bd1b7acz300az4847zb708zc1aef8b1adb1 · Cited by 1
The role of epigenetics in breast cancer progression
Yıldırım, A. (2013) · Utrecht University Repository (Utrecht University)
p53 and DNA damage checkpoint responses in the human prostate
af Hällström, T. (2007)
Li, K. (2010) · eScholarship@UMassChan · doi:10.13028/g001-qk95
Functions of the coregulator protein SNURF (RNF4) in transcription and cell growth
Häkli, M. (2005) · Helda - University of Helsinki Institutional Repository
Brooks, C. L. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-394447-4.30061-x
Self-citationThe Structure and Molecular Interactions of the Bromodomain
Yan, K. S., & Zhou, M. (2006) · Springer eBooks · doi:10.1007/0-387-24532-4_10
Hosako, H. (2009) · OakTrust (Texas A&M University Libraries)
Histone deacetylase inhibitors and Hodgkin's lymphoma
Gratwohl, A. A. (2011)
Fluctuations in network dynamics: SMAR1 can trigger apoptosisPreprint
Malik, M. Z., Alam, M. J., Ishrat, R., Agarwal, S. M., & Singh, R. K. B. (2015) · arXiv (Cornell University) · doi:10.48550/arxiv.1510.02718
INTEGRACIÓN DE LA FUNCIÓN DE VRK2 EN LAS RUTAS DE SEÑALIZACIÓN DE JNK Y P53.
Blanco, S. (2006) · DIGITAL.CSIC (Spanish National Research Council (CSIC))
A molecular ‘switchboard’ : lysine modifications and their impact on transcription.
Zheng, G. (2006) · OhioLink ETD Center (Ohio Library and Information Network)
Rosso, M. (2015) · CUNY Academic Works (City University of New York) · Cited by 1
Regulation of the tumor suppressor LKB1 by the acetyltransferase GCN5
Ghawitian, M. (2015) · theses.fr (ABES) · doi:10.70675/eb6cdaacza9dbz4ff8z9b39z9b9381d1b77a
Letienne, J. (2011) · Repository KITopen (Karlsruhe Institute of Technology) · doi:10.5445/ir/1000024812
Elucidating the role of ARKL1 in regulating Epstein-Barr virus (EBV) iinfection
Vaidya, A. (2016) · TSpace (University of Toronto)
Hydrophobic Modifications of Biomolecules: An Introduction
Ortega, Á. (2017) · Springer eBooks · doi:10.1007/978-3-319-20796-4_17-1
The role of PATZ1 transcription factor in the DNA damage response
Deniz, E. (2014) · Sabanci University
The Effects of Inhibiting PI3K on Tumor Suppressor Gene p53 and Cell Proliferation
Peters, K. (2018) · Digital Showcase Research, Scholarship, & Creative Works (University of Lynchburg)
Mimicry of p53 mono-ubiquitylation
Julier, A. (2019) · KOPS (University of Konstanz)
Chestley, T. (2017) · Mspace (University of Manitoba)
Characterization of NEK10 Tyrosine Kinase Activity in the Cellular Response to DNA Damage
Haider, N. (2018) · TSpace (University of Toronto) · Cited by 1
Bothwell, M. A. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.735708359.793577285
The role of microRNAs in the p53 tumor suppressor pathway
Zhang, X. (2011) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-3171
Hydrophobic Modifications of Biomolecules: An Introduction
Ortega, Á. (2018) · Springer eBooks · doi:10.1007/978-3-319-50542-8_17
Pinning Control to Regulate Cellular Response in Cancer for the p53-Mdm2 Genetic Regulatory Network
Suárez, O. J., Vega, C. J., Sanchez, E. N., Chen, G., Santiago, A. E. G., Rodríguez-Jorge, O., Alanís, A. Y., & Hernandez-Vargas, E. A. (2022) · Emergence, complexity and computation · doi:10.1007/978-3-031-04379-6_6
Brooks, C. L. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-821618-7.00251-0
Self-citationClinical and functional analysis of the germlineTP53p.K164E acetylation site variant
Pinto, E. M., Ribeiro, E. M. S. F., Wang, J., Phillips, A. H., Kriwacki, R. W., & Zambetti, G. P. (2023) · Molecular Case Studies · doi:10.1101/mcs.a006290
Germ cell tumor treatment resistance and liquid biopsy-based microRNA biomarkers
Timmerman, D. M. (2024) · Utrecht University Repository (Utrecht University) · doi:10.33540/2055
Satheesan, S. U., Chakrabarti, S., Fulzele, A., Marcellin, M., Locard‐Paulet, M., de Peredo, A. G., & Kolthur‐Seetharam, U. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.08.07.606949
Kienle, S. M., & Stuber, K. (2025) · ChemBioChem · doi:10.1002/cbic.202500444
Punga, T. (2003) · Uppsala University Publications (Uppsala University)
Xie, Q., Hu, B., & Li, H. (2024) · Figshare · doi:10.6084/m9.figshare.25802793
MTT cell viability, apoptosis detection and xCelligence real-time cell analysis
Bona, A., Moela, P., October, N., & Balemaken Missi, M. (2023) · UpSpace Institutional Repository (University of Pretoria) · doi:10.25403/upresearchdata.22068350
Xie, Q., Hu, B., & Li, H. (2024) · Figshare · doi:10.6084/m9.figshare.25802876
Tang, Y., Zhang, Z., Yan, T., Chen, K., Xu, G.-F., Xiong, S.-Q., Wu, D., Chen, J., Jose, P. A., Zeng, C.-Y., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26700598
Microtubule post-translational modifications and their impact on axonal transport
Bail, R. L. (2023) · ORBi (University of Liège)
Identification of MKRN1 as a key modulator of the p53-MDM2 feedback loop
Shimada, T., Noguchi, T., Komatsu, R., Otani, K., Komatsu, T., Suzuki, S., Mitsuya, M., Okubo, T., Ito, R., Yamada, M., et al. (2026) · Cell Death and Differentiation · doi:10.1038/s41418-026-01662-4
Ma, Y., Meng, X., Yin, X., Yu, Y., Lü, S., Gu, W., & Meng, Q. (2026) · Virulence · doi:10.64898/2026.03.02.708988
Self-citationNeural stem cells plasticity and differentiation
Flici, H. (2012) · theses.fr (ABES) · doi:10.70675/43448416z369fz4b50zb0d2z985989dbb1ed
Metadata
- Authors
- Li, M., Luo, J., Brooks, C. L., & Gu, W.
- Affiliations
- Columbia University (US)
- Corresponding author
- Gu, Wei
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2002-12
- Volume
- 277
- Issue
- 52
- Pages
- 50607-50611
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2082541302
- Cited by
- 503
- References
- 34
- Citations by year
- 2026: 11 · 2025: 14 · 2024: 19 · 2023: 16 · 2022: 23 · 2021: 21 · 2020: 14 · 2019: 15 · 2018: 17 · 2017: 22 · 2016: 15 · 2015: 18 · 2014: 27 · 2013: 33 · 2012: 27
- FWCI
- 10.01
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6528 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (5-T32-CAO9503-17, T32CA009503)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Keywords
- p53 acetylation, MDM2, ubiquitination, p53 stabilization, post-translational modification, DNA damage response, tumor suppressor regulation, site competition
- MeSH terms
- Acetylation, Animals, Burkitt Lymphoma, Cloning, Molecular, DNA Damage, HeLa Cells, Humans, Kinetics, Neoplasm Proteins, Nuclear Proteins, Protein Processing, Post-Translational, Proto-Oncogene Proteins, Recombinant Proteins, Tumor Cells, Cultured, Tumor Suppressor Protein p53, Ubiquitin, Proto-Oncogene Proteins c-mdm2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.